Clinical Trial Update: Effect of RBT-1 on Preconditioning Response Biomarkers in Subjects Undergoing CABG and/or Cardiac Valve Surgery [Phase 2]

View source ↗

Summary

Phase 2 trial update on RBT-1 evaluating preconditioning biomarkers in subjects undergoing CABG or cardiac valve surgery for acute kidney injury (AKI) outcomes;…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Injury

Drugs mentioned

• RBT-1

Snippet

Sponsor: Renibus Therapeutics, Inc. | Conditions: AKI | Phase 2 | Status: COMPLETED | Results posted: 2024-01-16